In PLOS One, researchers from China describe "immune-related gene pairs," or IRGPs, with apparent ties to outcomes for individuals with malignant melanoma. Using RNA sequencing data collected from almost 500 cutaneous melanoma cases for The Cancer Genome Atlas project, the team focused in on nearly three dozen IRGPs that appeared to correspond to overall survival in the melanoma cohort.